Last reviewed · How we verify

NCT06902831

Comparative Outcomes of Endoscopic and Open Carpal Tunnel Release with Neurotrophic Supplementation in Severe Carpal Tunnel Syndrome

Completed Last updated 30 March 2025
What this trial tests

trial testing Endoscopic Carpal Tunnel Release in Carpal Tunnel Syndrome (CTS) in 497 participants. Completed in 1 April 2024.

Timeline
1 June 2022
Primary endpoint
1 April 2024
1 April 2024

Quick facts

Lead sponsorUniversity of Bari
StatusCompleted
Study typeOBSERVATIONAL
Enrollment497
Start date1 June 2022
Primary completion1 April 2024
Estimated completion1 April 2024
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Bari

Who can join

18 and older, any sex, with Carpal Tunnel Syndrome (CTS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study addresses the pressing clinical question of optimizing surgical and pharmacological interventions for severe Carpal Tunnel Syndrome (CTS), a prevalent and debilitating condition caused by median nerve compression. Previous research has established the efficacy of Open Carpal Tunnel Release (OCTR) and Endoscopic Carpal Tunnel Release (ECTR); however, the role of neurotrophic supplementation in enhancing surgical outcomes has yet to be fully elucidated. Using a prospective clinical approach involving 497 patients, we evaluated the comparative outcomes of ECTR and OCTR with or without neurotrophic supplementation. Key findings demonstrate that ECTR, particularly when combined with neurotrophic agents, facilitates faster recovery and greater improvements in Sensory Nerve Conduction Velocity (VCS) and Visual Analog Scale (VAS) scores, with reduced complication rates compared to OCTR

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome (CTS)

Currently open trials in the same condition.

Other University of Bari trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06902831.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing